PedvaxHIB (Merck Sharp & Dohme Corp.)


Welcome to the PulseAid listing for the PedvaxHIB drug offered from Merck Sharp & Dohme Corp.. This Inactivated Haemophilus Influenzae B Vaccine [EPC],Actively Acquired Immunity [PE],Haemophilus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient] pharmaceutical is classified as a VACCINE. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.

LABELER NAME / MANUFACTURER: Merck Sharp & Dohme Corp.
NON-PROPRIETARY NAME: Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate)
SUBSTANCE NAME: HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN
TYPE: VACCINE
PHARMA CLASS: Inactivated Haemophilus Influenzae B Vaccine [EPC],Actively Acquired Immunity [PE],Haemophilus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient]
ROUTE: INTRAMUSCULAR
DOSAGE FORM: INJECTION, SUSPENSION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 1989-12-20
END MARKETING DATE: 0000-00-00


PedvaxHIB VACCINE Details:

Item DescriptionPedvaxHIB from Merck Sharp & Dohme Corp.
LABELER NAME: Merck Sharp & Dohme Corp.
DEA SCHEDULE:
ACTIVE STRENGTH: 7.5(ug/.5mL)
START MARKETING DATE: 1989-12-20
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0006-4897_96eff106-f303-4140-b50f-34ebb8ad0fb8
PRODUCT NDC: 0006-4897
APPLICATION NUMBER: BLA103237

Other HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Merck Sharp & Dohme Corp.PedvaxHIB